Cash

£28K

+18.4% vs 2020

Net assets

-£210K

-136.6% vs 2020

Employees

8

0% vs 2020

Profit before tax

Period ending 2021-12-31

Profile

Company number
11934279
Status
Active
Incorporation
2019-04-09
Last accounts made up
2024-12-31
Account category
FULL
Primary SIC
86220
Hubs
UK Healthcare

Net assets

3-year trend · vs UK Healthcare median

£0£1£1202020202021
SAPPHIRE CLINICS (LONDON) LIMITED

Accounts

3-year trend · latest 2021-12-31

Metric Trend 2020-04-302020-12-312021-12-31
Turnover
Operating profit
Profit before tax
Net profit
Cash £17,050£23,399£27,711
Total assets less current liabilities -£8,193-£55,789-£120,057
Net assets -£39,639-£88,692-£209,889
Equity -£39,639-£88,692-£209,889
Average employees 888
Wages

Values shown as filed in iXBRL accounts. indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Audit & accounting basis

From AI-extracted PDF accounts

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
PKF Littlejohn LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Company is reliant on the ongoing support of their parent company, Curaleaf International Limited, which itself is reliant on the ongoing support of the ultimate parent company, Curaleaf Holdings, Inc., a company registered in Canada. The parent company, Curaleaf International Limited, intends to provide ongoing support which will enable the Company to continue to fund its existing business operations and to invest in key growth projects over the coming 12 months. Based on the current cash balances and confirmed ongoing financial support of the parent company, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers

People

2 active · 7 resigned

Name Role Appointed Born Nationality
SAMRA, Aran Singh Director 2022-04-29 Dec 1986 British
SODERGREN, Mikael Hans, Dr Director 2019-04-09 Dec 1979 Swedish
Show 7 resigned officers
Name Role Appointed Resigned
ANAND, Praveen, Professor Director 2019-08-07 2021-12-03
BERI, Sushil Director 2019-08-07 2021-12-08
HOARE, Jonathan Martin, Dr Director 2019-08-07 2021-12-04
KHAN, Shaheen, Dr Director 2019-08-07 2021-12-08
PLATT, Michael William, Dr Director 2019-08-07 2021-12-02
RUCKER, James Jonathan Hamilton, Dr Director 2019-08-07 2021-12-02
WEATHERALL, Mark William, Dr Director 2019-08-07 2021-12-21

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Sapphire Medical Clinics Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2021-02-24 Active
Sapphire Medical Clinics Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2019-04-09 Ceased 2019-08-07

Filing timeline

Last 20 of 37 total filings

Date Type Category Description
2026-04-14 CS01 confirmation-statement confirmation statement with no updates
2025-10-06 AA accounts accounts with accounts type full
2025-05-13 CS01 confirmation-statement confirmation statement with no updates
2024-10-10 AA accounts accounts with accounts type full
2024-04-30 CS01 confirmation-statement confirmation statement with no updates
2023-10-12 AA accounts accounts with accounts type small
2023-06-21 CS01 confirmation-statement confirmation statement with no updates
2022-09-30 AA accounts accounts with accounts type unaudited abridged
2022-06-06 CS01 confirmation-statement confirmation statement with no updates
2022-05-04 AP01 officers appoint person director company with name date
2022-01-17 TM01 officers termination director company with name termination date
2022-01-17 TM01 officers termination director company with name termination date
2022-01-17 TM01 officers termination director company with name termination date
2022-01-17 TM01 officers termination director company with name termination date
2022-01-17 TM01 officers termination director company with name termination date
2022-01-17 TM01 officers termination director company with name termination date
2022-01-17 TM01 officers termination director company with name termination date
2021-12-09 AA accounts accounts with accounts type unaudited abridged
2021-11-08 AA01 accounts change account reference date company previous shortened
2021-04-09 CS01 confirmation-statement confirmation statement with updates

Credit score

Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage

Credit score requires total assets, EBIT (operating profit / PBT) — not present in the latest extracted accounts.

Activity Score

Composite activity score · components 0–100 · reference 2026-05-10

13.7

COLD

/ 100

  • Filings velocity 25
  • Capital events 0
  • Officer churn 0
  • Headcount trajectory 50
  • Accounts trajectory 0
  • 3 filing(s) in last 12 months
  • Employees +0% YoY
  • Net Assets -137% YoY

Official Companies House page